Chiesi Hellas

Headquartered in Parma since 1935, Chiesi is an international company with more than 85 years of experience and a strong focus on research, development, production and the commercialization of innovative medicines in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. Our production sites are in Parma, Italy, Blois (France) and Santana De Parnaiba (Brazil). The R&D centers in Parma (Italy), Paris (France), Cary (USA), Chippenham (UK) and the R&D team from the acquired Danish company Zymenex, integrate their efforts to advance Chiesis pre-clinical, clinical and registration programs. We export to more than 70 countries with a direct presence in 26. Our aim is to be recognized as a research-focused international Group, able to develop and commercialize innovative pharmaceutical solutions to improve the quality of human life. As a B Corp in the biopharmaceutical industry, Chiesi is counted among businesses that are leading a global movement for an inclusive,...